Cargando…

Further delineation of Loeys-Dietz syndrome type 4 in a family with mild vascular involvement and a TGFB2 splicing mutation

BACKGROUND: The Loeys-Dietz syndrome (LDS) is a rare autosomal dominant disorder characterized by thoracic aortic aneurysm and dissection and widespread systemic connective tissue involvement. LDS type 1 to 4 are caused by mutations in genes of the TGF-β signaling pathway: TGFBR1 and TGFBR2 encoding...

Descripción completa

Detalles Bibliográficos
Autores principales: Ritelli, Marco, Chiarelli, Nicola, Dordoni, Chiara, Quinzani, Stefano, Venturini, Marina, Maroldi, Roberto, Calzavara-Pinton, Piergiacomo, Colombi, Marina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4236574/
https://www.ncbi.nlm.nih.gov/pubmed/25163805
http://dx.doi.org/10.1186/s12881-014-0091-8
_version_ 1782345193233580032
author Ritelli, Marco
Chiarelli, Nicola
Dordoni, Chiara
Quinzani, Stefano
Venturini, Marina
Maroldi, Roberto
Calzavara-Pinton, Piergiacomo
Colombi, Marina
author_facet Ritelli, Marco
Chiarelli, Nicola
Dordoni, Chiara
Quinzani, Stefano
Venturini, Marina
Maroldi, Roberto
Calzavara-Pinton, Piergiacomo
Colombi, Marina
author_sort Ritelli, Marco
collection PubMed
description BACKGROUND: The Loeys-Dietz syndrome (LDS) is a rare autosomal dominant disorder characterized by thoracic aortic aneurysm and dissection and widespread systemic connective tissue involvement. LDS type 1 to 4 are caused by mutations in genes of the TGF-β signaling pathway: TGFBR1 and TGFBR2 encoding the TGF-β receptor (LDS1 and LDS2), SMAD3 encoding the TGF-β receptor cytoplasmic effector (LDS3), and TGFB2 encoding the TGF-β2 ligand (LDS4). LDS4 represents the mildest end of the LDS spectrum, since aneurysms are usually observed in fourth decade and the progression of the disease is slower than in the other forms. CASE PRESENTATION: We report the clinical and molecular findings of an LDS4 Italian family. Genetic testing included TGFBR1, TGFBR2, SMAD3, and TGFB2 analysis by Sanger sequencing. In order to verify the effect of the identified splice mutation, RT-PCR analysis was performed. The proband, a 57-year-old woman, showed high palate, hypoplasic uvula, easy bruising, joint hypermobility, chronic pain, scoliosis, multiple relapsing hernias, dural ectasia, and mitral valve prolapse. Magnetic resonance angiography revealed tortuosity and ectasia of carotid, vertebral, cerebral, and segmental pulmonary arteries. Arterial aneurysm and dissection never occurred. Her 39- and 34-year-old daughters presented with a variable degree of musculoskeletal involvement. Molecular analysis disclosed the novel c.839-1G>A splice site mutation in the TGFB2 gene. This mutation activates a cryptic splice acceptor site in exon 6 leading to frameshift, premature termination codon and haploinsufficiency (p.Gly280Aspfs*41). CONCLUSIONS: Our data confirm that loss-of-function mutations in TGFB2 gene do not always lead to aggressive vascular phenotypes and that articular and skeletal signs are prevalent, therefore suggesting that LDS4 must be considered in patients with sparse signs of LDS and related disorders also in the absence of vascular events.
format Online
Article
Text
id pubmed-4236574
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-42365742014-11-19 Further delineation of Loeys-Dietz syndrome type 4 in a family with mild vascular involvement and a TGFB2 splicing mutation Ritelli, Marco Chiarelli, Nicola Dordoni, Chiara Quinzani, Stefano Venturini, Marina Maroldi, Roberto Calzavara-Pinton, Piergiacomo Colombi, Marina BMC Med Genet Case Report BACKGROUND: The Loeys-Dietz syndrome (LDS) is a rare autosomal dominant disorder characterized by thoracic aortic aneurysm and dissection and widespread systemic connective tissue involvement. LDS type 1 to 4 are caused by mutations in genes of the TGF-β signaling pathway: TGFBR1 and TGFBR2 encoding the TGF-β receptor (LDS1 and LDS2), SMAD3 encoding the TGF-β receptor cytoplasmic effector (LDS3), and TGFB2 encoding the TGF-β2 ligand (LDS4). LDS4 represents the mildest end of the LDS spectrum, since aneurysms are usually observed in fourth decade and the progression of the disease is slower than in the other forms. CASE PRESENTATION: We report the clinical and molecular findings of an LDS4 Italian family. Genetic testing included TGFBR1, TGFBR2, SMAD3, and TGFB2 analysis by Sanger sequencing. In order to verify the effect of the identified splice mutation, RT-PCR analysis was performed. The proband, a 57-year-old woman, showed high palate, hypoplasic uvula, easy bruising, joint hypermobility, chronic pain, scoliosis, multiple relapsing hernias, dural ectasia, and mitral valve prolapse. Magnetic resonance angiography revealed tortuosity and ectasia of carotid, vertebral, cerebral, and segmental pulmonary arteries. Arterial aneurysm and dissection never occurred. Her 39- and 34-year-old daughters presented with a variable degree of musculoskeletal involvement. Molecular analysis disclosed the novel c.839-1G>A splice site mutation in the TGFB2 gene. This mutation activates a cryptic splice acceptor site in exon 6 leading to frameshift, premature termination codon and haploinsufficiency (p.Gly280Aspfs*41). CONCLUSIONS: Our data confirm that loss-of-function mutations in TGFB2 gene do not always lead to aggressive vascular phenotypes and that articular and skeletal signs are prevalent, therefore suggesting that LDS4 must be considered in patients with sparse signs of LDS and related disorders also in the absence of vascular events. BioMed Central 2014-08-28 /pmc/articles/PMC4236574/ /pubmed/25163805 http://dx.doi.org/10.1186/s12881-014-0091-8 Text en Copyright © 2014 Ritelli et al.; BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Case Report
Ritelli, Marco
Chiarelli, Nicola
Dordoni, Chiara
Quinzani, Stefano
Venturini, Marina
Maroldi, Roberto
Calzavara-Pinton, Piergiacomo
Colombi, Marina
Further delineation of Loeys-Dietz syndrome type 4 in a family with mild vascular involvement and a TGFB2 splicing mutation
title Further delineation of Loeys-Dietz syndrome type 4 in a family with mild vascular involvement and a TGFB2 splicing mutation
title_full Further delineation of Loeys-Dietz syndrome type 4 in a family with mild vascular involvement and a TGFB2 splicing mutation
title_fullStr Further delineation of Loeys-Dietz syndrome type 4 in a family with mild vascular involvement and a TGFB2 splicing mutation
title_full_unstemmed Further delineation of Loeys-Dietz syndrome type 4 in a family with mild vascular involvement and a TGFB2 splicing mutation
title_short Further delineation of Loeys-Dietz syndrome type 4 in a family with mild vascular involvement and a TGFB2 splicing mutation
title_sort further delineation of loeys-dietz syndrome type 4 in a family with mild vascular involvement and a tgfb2 splicing mutation
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4236574/
https://www.ncbi.nlm.nih.gov/pubmed/25163805
http://dx.doi.org/10.1186/s12881-014-0091-8
work_keys_str_mv AT ritellimarco furtherdelineationofloeysdietzsyndrometype4inafamilywithmildvascularinvolvementandatgfb2splicingmutation
AT chiarellinicola furtherdelineationofloeysdietzsyndrometype4inafamilywithmildvascularinvolvementandatgfb2splicingmutation
AT dordonichiara furtherdelineationofloeysdietzsyndrometype4inafamilywithmildvascularinvolvementandatgfb2splicingmutation
AT quinzanistefano furtherdelineationofloeysdietzsyndrometype4inafamilywithmildvascularinvolvementandatgfb2splicingmutation
AT venturinimarina furtherdelineationofloeysdietzsyndrometype4inafamilywithmildvascularinvolvementandatgfb2splicingmutation
AT maroldiroberto furtherdelineationofloeysdietzsyndrometype4inafamilywithmildvascularinvolvementandatgfb2splicingmutation
AT calzavarapintonpiergiacomo furtherdelineationofloeysdietzsyndrometype4inafamilywithmildvascularinvolvementandatgfb2splicingmutation
AT colombimarina furtherdelineationofloeysdietzsyndrometype4inafamilywithmildvascularinvolvementandatgfb2splicingmutation